Medical tourism is a growing industry, with Türkiye’s official international health-services organisation, USHAŞ, reporting 563,327 health-tourism patients and approximately $1.58 billion in related revenue for the second quarter of 2026. However, the journey from initial interest to treatment is often unclear, leading to uncertainty and mistrust among patients.
A patient considering treatment abroad is not just choosing a hospital, but also deciding whether to trust a clinical team they have never met and share sensitive medical information. By the time they enquire, uncertainty is already part of the journey, and providers must invest heavily in creating a clear and supportive patient journey.
The problem lies in the handover between different teams and individuals, where delays, inconsistent information, and uncertainty about who owns the next step can occur.
This can lead to patients feeling abandoned, even if the clinic classifies the enquiry as active. Geography can exacerbate the issue, with clinics operating on local office hours receiving enquiries from patients living several time zones away.
The Patient Journey
A patient seeking treatment abroad may send their first message through WhatsApp on a Sunday evening, and a coordinator may reply on Monday morning with a price estimate. However, this sequence can create room for delay, inconsistent information, and uncertainty about who owns the next step.
The clinician may not yet have reviewed whether treatment is appropriate, and the patient may already feel abandoned.
Cross-border treatment makes these gaps more consequential, as patients weigh clinical quality, travel arrangements, cost, language, recovery time, and what happens if complications arise after they return home. An unanswered question can alter their judgement of the provider’s competence before a clinical conversation has even begun.
Evidence from the OECD suggests that patients who have to repeat information already provided report trust and experienced care quality approximately 15 percentage points lower, on average, than patients who do not. Measures of person-centred care were roughly 20 percentage points lower.
In international healthcare, operational clarity is key. Patients should not repeat their medical history with each new contact, and pricing must be transparent. Pending clinical reviews require clear explanations of who is involved and when to expect a response. Financial transparency is equally important, as uncertainty can extend to diagnostics, accommodation, medication, revised plans, and follow-up care. The Australian Government’s consultation on informed financial consent shows the need for clear communication in healthcare.
Measuring Success
Many healthcare organisations can report the number of leads generated by an advertising campaign, but far fewer can explain what happened to each person afterwards. A full pipeline can hide a weak process, and increasing advertising spend will not solve all the problems that occur during the patient journey.
The basic measurements should include time to the first meaningful response, successful contact rate, clinically appropriate qualification, consultation booking and attendance, treatment decision, time between stages, and recorded reasons for disengagement. Classification matters as much as counting, and a patient who declines an unsuitable procedure should not be recorded alongside someone who disappeared after three unanswered messages.
The use of digital systems can help providers record enquiries, assign ownership, monitor response times, and identify patients waiting for clinical information. However, technology should not be relied upon to create trust by itself, but rather to support informed human communication. The value lies not in the dashboard itself, but in the action somebody takes because the information is visible, such as following up on an unanswered question or clarifying recovery arrangements.
Leave a Reply